LPL Financial’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$320K Buy
103,756
+55,130
+113% +$234K ﹤0.01% 5147
2025
Q4
$176K Sell
48,626
-12,898
-21% -$56.2K ﹤0.01% 5480
2025
Q3
$232K Sell
61,524
-13,969
-19% -$53.9K ﹤0.01% 5246
2025
Q2
$292K Buy
75,493
+8,912
+13% +$48.2K ﹤0.01% 4793
2025
Q1
$333K Buy
66,581
+8,408
+14% +$53.3K ﹤0.01% 4501
2024
Q4
$419K Buy
58,173
+7,693
+15% +$58.8K ﹤0.01% 4244
2024
Q3
$310K Sell
50,480
-1,182
-2% -$8.01K ﹤0.01% 4406
2024
Q2
$344K Sell
51,662
-1,767
-3% -$13K ﹤0.01% 4166
2024
Q1
$544K Buy
53,429
+18,987
+55% +$193K ﹤0.01% 3706
2023
Q4
$387K Buy
+34,442
New +$144K ﹤0.01% 3876
2016
Q2
Sell
-33
Closed -$21K 2634
2016
Q1
$21K Buy
+33
New +$16.9K ﹤0.01% 3056

Other funds holding ALT

LPL Financial's ALT Position: Q1 2026 in Review

LPL Financial increased its Altimmune (ALT) stake by 113% in Q1 2026, buying an estimated $234K and bringing the position to 103,756 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #5147.

LPL Financial first reported a position in ALT in Q1 2016 and has held it in 11 quarters since. The position peaked at $544K in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • LPL Financial held 103,756 shares of Altimmune worth $320K as of Q1 2026.
  • LPL Financial bought 55,130 Altimmune shares in Q1 2026, an estimated $234K.
  • Altimmune made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5147 holding.
  • LPL Financial first reported a position in Altimmune in Q1 2016 and has held it in 11 quarters since.
  • LPL Financial's Altimmune position peaked at $544K in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.